First look: psoriasis drug tested in kids
NCT ID NCT03240809
Summary
This study is checking the safety and how a single dose of the drug brodalumab moves through the body in children and teenagers with severe plaque psoriasis. It involves a very small group of participants, aged 6 to under 18. The main goal is to gather initial information on how children handle this medication, which is already used for adults.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bausch Site 001
Las Vegas, Nevada, 45242, United States
-
Bausch Site 002
Miami, Florida, 33155, United States
-
Bausch Site 003
San Diego, California, 92123, United States
-
Bausch Site 004
Miami, Florida, 33155, United States
-
Bausch Site 005
Henderson, Nevada, 89052, United States
Conditions
Explore the condition pages connected to this study.